Published in Nat Genet on March 01, 1999
Structure and mechanism of a Na+-independent amino acid transporter. Science (2009) 3.30
CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J (2000) 3.12
A system for specific, high-throughput genotyping by allele-specific primer extension on microarrays. Genome Res (2000) 2.94
CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch (2003) 2.69
Pathophysiology and treatment of cystinuria. Nat Rev Nephrol (2010) 1.40
Molecular basis of substrate-induced permeation by an amino acid antiporter. Proc Natl Acad Sci U S A (2011) 1.37
The Finnish Disease Heritage III: the individual diseases. Hum Genet (2003) 1.36
Organization of the pronephric kidney revealed by large-scale gene expression mapping. Genome Biol (2008) 1.31
Nonvesicular release of glutamate by glial xCT transporters suppresses glutamate receptor clustering in vivo. J Neurosci (2007) 1.20
Projection structure of a member of the amino acid/polyamine/organocation transporter superfamily. J Biol Chem (2008) 1.19
Luminal heterodimeric amino acid transporter defective in cystinuria. Mol Biol Cell (1999) 1.15
Vascular endothelial dysfunction resulting from L-arginine deficiency in a patient with lysinuric protein intolerance. J Clin Invest (2001) 1.06
Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. J Clin Invest (2010) 1.04
Kidney amino acid transport. Pflugers Arch (2009) 1.03
Rare lung disease II: pulmonary alveolar proteinosis. Can Respir J (2008) 0.99
Successful whole lung lavage in pulmonary alveolar proteinosis secondary to lysinuric protein intolerance: a case report. Orphanet J Rare Dis (2007) 0.98
Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance. Am J Hum Genet (2000) 0.96
Expression of heteromeric amino acid transporters along the murine intestine. J Physiol (2004) 0.95
The molecular and genetic base of congenital transport defects. Gut (2000) 0.93
The catalytic subunit of the system L1 amino acid transporter (slc7a5) facilitates nutrient signalling in mouse skeletal muscle. PLoS One (2014) 0.92
Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeat. Eur J Hum Genet (2008) 0.91
Substrate binding tunes conformational flexibility and kinetic stability of an amino acid antiporter. J Biol Chem (2009) 0.89
Role of plasma membrane transporters in muscle metabolism. Biochem J (2000) 0.88
A L-lysine transporter of high stereoselectivity of the amino acid-polyamine-organocation (APC) superfamily: production, functional characterization, and structure modeling. J Biol Chem (2013) 0.85
Growth hormone deficiency in a patient with lysinuric protein intolerance. Eur J Pediatr (2006) 0.81
Lysine nutrition in swine and the related monogastric animals: muscle protein biosynthesis and beyond. Springerplus (2015) 0.81
Nutrient intake in lysinuric protein intolerance. J Inherit Metab Dis (2007) 0.81
Inherited epithelial transporter disorders--an overview. J Inherit Metab Dis (2008) 0.81
Hepatic adaptation compensates inactivation of intestinal arginine biosynthesis in suckling mice. PLoS One (2013) 0.80
SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance. Orphanet J Rare Dis (2009) 0.78
Role of transmembrane domain 8 in substrate selectivity and translocation of SteT, a member of the L-amino acid transporter (LAT) family. J Biol Chem (2010) 0.78
Inborn errors of metabolism underlying primary immunodeficiencies. J Clin Immunol (2014) 0.77
Growth hormone therapy is safe and effective in patients with lysinuric protein intolerance. JIMD Rep (2011) 0.77
Cloning and molecular characterization of cationic amino acid transporter y⁺LAT1 in grass carp (Ctenopharyngodon idellus). Fish Physiol Biochem (2013) 0.76
Renal Involvement in a French Paediatric Cohort of Patients with Lysinuric Protein Intolerance. JIMD Rep (2015) 0.76
Lung involvement in children with lysinuric protein intolerance. J Inherit Metab Dis (2014) 0.76
Update on Lysinuric Protein Intolerance, a Multi-faceted Disease Retrospective cohort analysis from birth to adulthood. Orphanet J Rare Dis (2017) 0.75
Urine Beta2-Microglobulin Is an Early Marker of Renal Involvement in LPI. JIMD Rep (2015) 0.75
Lysinuric Protein Intolerance Presenting with Multiple Fractures. Mol Genet Metab Rep (2014) 0.75
Blood-brain barrier transport machineries and targeted therapy of brain diseases. Bioimpacts (2016) 0.75
Fanconi syndrome with lysinuric protein intolerance. Clin Kidney J (2014) 0.75
Growth Hormone Deficiency and Lysinuric Protein Intolerance: Case Report and Review of the Literature. JIMD Rep (2015) 0.75
Pregnancy and lactation outcomes in a Turkish patient with lysinuric protein intolerance. JIMD Rep (2013) 0.75
Testing the hypothesis that system y(+)L accounts for high- and low-transport phenotypes in chicken erythrocytes using L-leucine as substrate. J Membr Biol (2005) 0.75
Spectrophotometric quantitation of antioxidant capacity through the formation of a phosphomolybdenum complex: specific application to the determination of vitamin E. Anal Biochem (1999) 8.50
Classification of European mtDNAs from an analysis of three European populations. Genetics (1996) 6.28
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09
The origin of the major cystic fibrosis mutation (delta F508) in European populations. Nat Genet (1994) 4.94
mtDNA analysis reveals a major late Paleolithic population expansion from southwestern to northeastern Europe. Am J Hum Genet (1998) 3.94
A signal, from human mtDNA, of postglacial recolonization in Europe. Am J Hum Genet (2001) 3.28
Prospective randomised trial in 1062 infants of diet low in saturated fat and cholesterol. Lancet (1995) 3.13
Molecular biology of mammalian plasma membrane amino acid transporters. Physiol Rev (1998) 3.10
A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet (1991) 3.07
A deletion in chromosome 22 can cause DiGeorge syndrome. Hum Genet (1981) 3.04
Genes and languages in Europe: an analysis of mitochondrial lineages. Genome Res (1995) 2.93
Raised plasma-ornithine and gyrate atrophy of the choroid and retina. Lancet (1973) 2.56
Human mitochondrial DNA types in Finland. Hum Genet (1988) 2.53
Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. Neurology (2012) 2.53
Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia (2012) 2.41
Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Eur J Hum Genet (1996) 2.40
mtDNA variation in the South African Kung and Khwe-and their genetic relationships to other African populations. Am J Hum Genet (2000) 2.35
Leber's hereditary optic neuroretinopathy, a maternally inherited disease. A genealogic study in four pedigrees. Arch Ophthalmol (1987) 2.18
Nutrient intakes by young children in a prospective randomized trial of a low-saturated fat, low-cholesterol diet. The STRIP Baby Project. Special Turku Coronary Risk Factor Intervention Project for Babies. Arch Pediatr Adolesc Med (1997) 2.16
Investigating genotype-phenotype relationships in Rett syndrome using an international data set. Neurology (2008) 2.10
Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Invest (1993) 2.10
Meiotic drive at the myotonic dystrophy locus? Nat Genet (1994) 2.08
Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia (2010) 2.08
West syndrome: individualized ACTH therapy. Brain Dev (1997) 2.07
Isolation of a new DNA marker in linkage disequilibrium with cystic fibrosis, situated between J3.11 (D7S8) and IRP. Am J Hum Genet (1989) 1.97
Optic atrophy in Leber hereditary optic neuroretinopathy is probably determined by an X-chromosomal gene closely linked to DXS7. Am J Hum Genet (1991) 1.89
Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy (2009) 1.87
Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia (2001) 1.82
Congenital nephrotic syndrome: prenatal diagnosis and genetic counselling by estimation of aminotic-fluid and maternal serum alpha-fetoprotein. Lancet (1976) 1.82
Convenient and quantitative determination of the frequency of a mutant allele using solid-phase minisequencing: application to aspartylglucosaminuria in Finland. Genomics (1992) 1.81
Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus. J Clin Invest (1992) 1.80
Expression cloning of a cDNA from rabbit kidney cortex that induces a single transport system for cystine and dibasic and neutral amino acids. Proc Natl Acad Sci U S A (1992) 1.78
Risk of minor and major fetal malformations in diabetics with high haemoglobin A1c values in early pregnancy. Br Med J (Clin Res Ed) (1984) 1.77
A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat Genet (1999) 1.76
Lack of immune responsiveness to bovine serum albumin in insulin-dependent diabetes. N Engl J Med (1993) 1.75
Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biol Chem (1999) 1.72
Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology (1996) 1.71
Genetic heterogeneity in Leber hereditary optic neuroretinopathy revealed by mitochondrial DNA polymorphism. Am J Hum Genet (1989) 1.70
Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (bo,+AT) of rBAT. Nat Genet (1999) 1.65
The effect of genotype on the natural history of eIF2B-related leukodystrophies. Neurology (2004) 1.63
The cytogenetic effects of mycoplasma in human leukocyte cultures. J Cell Physiol (1967) 1.62
Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab (1998) 1.60
Chromosome damage associated with the measles virus in vitro. Hereditas (1965) 1.60
Niemann-Pick C disease in Spain: clinical spectrum and development of a disability scale. J Neurol Sci (2006) 1.58
Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes (2000) 1.58
Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry (1995) 1.57
Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem (1996) 1.56
Genetic aspects in gyrate atrophy of the choroid and retina with hyperornithinaemia. Br J Ophthalmol (1974) 1.54
Reduced steady-state levels of mitochondrial RNA and increased mitochondrial DNA amount in human brain with aging. Brain Res Mol Brain Res (1997) 1.53
The search for south European cystic fibrosis mutations: identification of two new mutations, four variants, and intronic sequences. Genomics (1991) 1.51
Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes. Diabetologia (2011) 1.51
Identification and characterization of a membrane protein (y+L amino acid transporter-1) that associates with 4F2hc to encode the amino acid transport activity y+L. A candidate gene for lysinuric protein intolerance. J Biol Chem (1998) 1.50
Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes (2000) 1.50
Methionine in paracetamol tablets, a tool to reduce paracetamol toxicity. Int J Clin Pharmacol Ther Toxicol (1985) 1.50
Sodium intake of 1 to 5-year-old children: the STRIP project. The Special Turku Coronary Risk Factor Intervention Project. Acta Paediatr (2000) 1.48
CA/GT microsatellite alleles within the cystic fibrosis transmembrane conductance regulator (CFTR) gene are not generated by unequal crossingover. Genomics (1991) 1.46
Segregation of mitochondrial genomes in a heteroplasmic lineage with Leber hereditary optic neuroretinopathy. Am J Hum Genet (1990) 1.46
The genetic relationship between the Finns and the Finnish Saami (Lapps): analysis of nuclear DNA and mtDNA. Am J Hum Genet (1996) 1.46
Population-based genetic screening for the estimation of Type 1 diabetes mellitus risk in Finland: selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med (1999) 1.42
Relation among mannose-binding lectin 2 genotype, beta-cell autoantibodies, and risk for type 1 diabetes in Finnish children. Hum Immunol (2008) 1.42
Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure? Diabetologia (2003) 1.41
Age at introduction of new foods and advanced beta cell autoimmunity in young children with HLA-conferred susceptibility to type 1 diabetes. Diabetologia (2006) 1.41
"Salla disease": a new lysosomal storage disorder. Arch Neurol (1979) 1.40
HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens (2003) 1.39
Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia. Neurology (1999) 1.39
Absence of IgA and growth hormone deficiency associated with short arm deletion of chromosome 18. Arch Dis Child (1973) 1.38
[Diabetes mellitus associated with the A3243G mutation of mitochondrial DNA. Apropos a case]. Med Clin (Barc) (1999) 1.38
The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab (2001) 1.37
Heteromeric amino acid transporters: biochemistry, genetics, and physiology. Am J Physiol Renal Physiol (2001) 1.37
Role of two upstream open reading frames in the translational control of oncogene mdm2. Oncogene (1999) 1.37
Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13. Nat Genet (1996) 1.36
Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. EMBO J (1991) 1.33
Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. Diabetes (1999) 1.32
Hepatitis B knowledge among Vietnamese immigrants: implications for prevention of hepatocellular carcinoma. J Cancer Educ (2000) 1.32
Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia (2006) 1.31
Microsatellite haplotypes for cystic fibrosis: mutation frameworks and evolutionary tracers. Hum Mol Genet (1993) 1.31
Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia. J Clin Invest (1992) 1.30
Electron transfer properties of NADH:ubiquinone reductase in the ND1/3460 and the ND4/11778 mutations of the Leber hereditary optic neuroretinopathy (LHON). FEBS Lett (1991) 1.29
Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. Am J Epidemiol (1997) 1.29